Table 1.
The demographics and clinical characteristics between patients with COVID-19
| Characteristic | Group | P value | |
|---|---|---|---|
| BMI < 24 | BMI ≥ 24 | ||
| Sample size, n | 59 | 37 | – |
| Sex (male), n (%) | 31 (52.5) | 23 (62.2) | 0.355 |
| Age (years) | 35.41 ± 18.45 | 44.00 ± 17.23 | 0.025 |
| Systolic blood pressure | 124.84 ± 16.11 | 126.29 ± 15.51 | 0.666 |
| Diastolic blood pressure | 81.13 ± 9.61 | 85.57 ± 10.08 | 0.035 |
| Creatine kinase | 84.04 ± 112.12 | 169.37 ± 212.25 | 0.013 |
| Serum lactic acid | 1.64 ± 0.70 | 1.39 ± 0.65 | 0.123 |
| Neutrophil count | 3.33 ± 1.50 | 3.31 ± 1.41 | 0.927 |
| Lymphocyte count | 1.46 ± 1.04 | 1.19 ± 0.61 | 0.169 |
| Hemoglobin | 139.22 ± 15.07 | 142.51 ± 19.95 | 0.361 |
| Platelet count | 222.23 ± 66.42 | 180.89 ± 51.92 | 0.002 |
| Serum creatinine | 60.58 ± 19.09 | 70.19 ± 15.18 | 0.012 |
| ALT | 20.38 ± 16.65 | 26.22 ± 18.51 | 0.118 |
| AST | 21.70 ± 8.59 | 26.05 ± 13.88 | 0.065 |
| Lactate dehydrogenase | 177.82 ± 54.39 | 221.94 ± 73.21 | 0.001 |
| Smoking tobacco, n (%) | 5 (8.5) | 3 (8.1) | 0.950 |
ALT Alanine aminotransferase; AST Aspartate aminotransferase